PBA
Paradigm Biocapital Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1M | Hold |
4,236,346
| – | – | 0.82% | 24 |
|
|
2025
Q1 | $18.8M | Hold |
4,236,346
| – | – | 0.86% | 24 |
|
|
2024
Q4 | $33.2M | Buy |
4,236,346
+150,000
| +4% | +$1.17M | 1.15% | 22 |
|
|
2024
Q3 | $53.7M | Buy |
4,086,346
+215,752
| +6% | +$2.84M | 1.82% | 16 |
|
|
2024
Q2 | $46.8M | Buy |
3,870,594
+1,636,984
| +73% | +$19.8M | 1.79% | 19 |
|
|
2024
Q1 | $36.3M | Buy |
+2,233,610
| New | +$36.3M | 1.28% | 23 |
|